Kevin R. Kaster

Former Sr. VP Corporate Development at Threshold Pharmaceuticals, Inc.

Are you Kevin R. Kaster? Claim your profile
 
  • IDENTIFY corporate executives in Kevin R. Kaster's network and community.
  • FOLLOW changes in Kevin R. Kaster's employment and money-in-motion.
  • CONNECT with Kevin R. Kaster through your network of contacts.

Kevin R. Kaster's Executive Work History


Past
To view Kevin R. Kaster's complete executive work history,
Education
Age
57
 

Kevin R. Kaster's Biography


Mr. Kaster has over 25 years of experience in both smaller biotechnology firms and large pharmaceutical companies. He has an impressive track record of developing effective patent and licensing strategies for important technologies and drug products. Mr. Kaster was formerly the VP Intellectual Properties at Kosan Biosciences, which had geldanamycin and epothilone anti-cancer agents in its pipeline and was acquired by Bristol-Myers Squibb in 2008. Prior to Kosan, he was the VP of Intellectual Property at Geron Corporation. Geron owns rights in telomerase and human embryonic stem cell technologies. Prior to Geron, he was Director of Intellectua ...

(Read More)

Source: Centrose LLC on 04/06/2007

 
 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Kevin R. Kaster. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Kevin R. Kaster's network and community.
  • FOLLOW changes in Kevin R. Kaster's employment and money-in-motion.
  • CONNECT with Kevin R. Kaster through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Kevin R. Kaster

Kevin R. Kaster's Connections (27)


Chairman, President and Chief Executive Officer, Kura Oncology, Inc.
Lead Independent Director, DURECT Corporation
Senior Vice President, Chief Financial Officer and Chief Business Officer, Dynavax Technologies Corporation
Executive Vice President, Chief Financial and Administrative Officer and Secretary, ChemoCentryx, Inc.
Former Chief Operating Officer, Threshold Pharmaceuticals, Inc.